I-Mab Biopharma

I-Mab Biopharma Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

I-MabBiopharma key operating metrics including Clinical and Pre-Clinical Stage Assets Developed.

Clinical and Pre-Clinical Stage Assets Developed

Q3, 2019

Patents Issued

Q3, 2019

Patents Pending

156

Q3, 2019

Operating Metrics

Metrics	Q3, 2019
Clinical and Pre-Clinical Stage Assets Developed	10
Patents Issued	5
Patents Pending	156
Partners	10